US Stock MarketDetailed Quotes

DMTK DermTech

Watchlist

0.591
-0.001-0.17%

Close Apr 18 16:00 ET

0.623
+0.032+5.48%

Post 19:30 ET

20.46MMarket Cap-191P/E (TTM)

DermTech Stock Forum

Moomoo AI

Feb 1 07:25

DermTech's low P/S ratio is likely due to limited future growth expectations. Poor revenue performance and a lower-than-industry growth forecast have reduced investor willingness to pay more for the stock. A significant change in fortune is needed for a higher P/S ratio.

DermTech, Inc. (NASDAQ:DMTK) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough

Trytosaveabit

Jan 31 15:44

Update

$DermTech(DMTK.US)$ DermTech Announces Restructuring Actions And Emphasis On Growing Revenue For DermTech Melanoma Test ; Co. To Reduce 15% Of Workforce, Expects ~$40M In Total Operating Expense Reductions

Trytosaveabit

Jan 18 07:14

Update

$DermTech(DMTK.US)$ DermTech Announces Topline Results From Study Evaluating DermTech Melanoma Test Across All Skin Types; Negative Predictive Value Higher Than 99% Regardless Of Skin Type

AmyNic

Nov 2, 2023 16:03

ok 👀 👀

$DermTech(DMTK.US)$

Sam Wallstreet

Jan 13, 2023 10:04

QUICK SCALP 5 $DMTK — STOCK & OPTION PLAY
ALERT ON: $5.08
ON THE WATCH: $5.15
🥇 SIGNED OF MORE UPTREND: $5.23
NEED IT TO BREAK OVER: $5.37
key indicator for MORE uptrend $5.52
confirmation uptrend - $5.73
mini breakout - $5.95. $DermTech(DMTK.US)$

GAME_DAY

Jan 10, 2023 17:34

AH+1/11 Watchlist

follow for nightly watchlist ⚡️
$AbbVie(ABBV.US)$$Broadcom(AVGO.US)$$BioAtla(BCAB.US)$$Biora Therapeutics(BIOR.US)$$DermTech(DMTK.US)$ $Broadwind(BWEN.US)$$CureVac(CVAC.US)$$EVgo Inc(EVGO.US)$$Hepion Pharmaceuticals(HEPA.US)$$AMTD Digital(HKD.US)$$Ichor Holdings(ICHR.US)$$MasterCard(MA.US)$$NextPlay Technologies(NXTP.US)$$Party City Holdco(PRTY.US)$$Starbucks(SBUX.US)$

Moomoo Breakfast US

May 19, 2022 07:15

ColumnsToday's pre-market stock movers: GOOS, TSLA, KSS, UAA and more

Gainers:
• $Rocket Pharmaceuticals(RCKT.US)$ +10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy)
• $Canada Goose(GOOS.US)$ +9.4% (the company reported an unexpected profit as well as better-than-expected revenue)
• $SIGA Technologies(SIGA.US)$ +6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...